EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudie

Effect of pretreatment HIV drug resistance on mortality, attrition and viral suppression in patients initiating antiretroviral therapy and genetic transmission network: an observational cohort study in Southwest China

Litai Qin, Yihong Xie, Jianjun Li iD, Ge Zhong, Jin Chen, Qiuying Zhu, Shujia Liang, Hui Xing iD, Lingjie Liao iD, Yi Feng, Yiming Shao iD, Yuhua Ruan und 2 weitere

Journal of Antimicrobial Chemotherapy · 2026

DOI: 10.1093/jac/dkag073 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Litai Qin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Guangxi Medical University, Nanning 530028, China. Hauptthemen laut MEDLINE: HIV Infections, Drug Resistance, Viral, Anti-HIV Agents, HIV-1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangxi Key Research and Development Program, Ministry of Science and Technology of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Pretreatment drug resistance (PDR) compromises antiretroviral therapy (ART) efficacy and is a major concern in HIV care, yet its consequences for key treatment outcomes are not well-defined. We therefore systematically investigated the prevalence of PDR and its impact on mortality, attrition and viral suppression amongst patients starting ART.

Methods

An observational cohort study was conducted in Southwest China, 2014–2022. PDR was analysed using the Stanford HIV Drug Resistance Database. Molecular transmission networks were constructed with HIV-TRACE. Cox and logistic regression evaluated the impact of PDR.

Results

Amongst 3478 eligible patients, the overall prevalence of PDR was 6.4%. PDR rates to non-nucleoside reverse transcriptase inhibitors (NNRTIs), nucleoside reverse transcriptase inhibitors and protease inhibitors were 4.1%, 1.3% and 1.1%, respectively. The overall mortality and attrition rates were 4.58 and 2.40 per 100 person-years, respectively. Whilst PDR showed no significant association with mortality, it was associated with increased attrition. Compared to those without resistance, the adjusted HR (95% CI) for attrition was 1.67 (1.11–2.52) in the overall drug-resistant group, 2.16 (1.36–3.43) in the NNRTI-resistant group and 2.09 (1.10–3.97) in the efavirenz/nevirapine-resistant group. Viral suppression was significantly lower in the drug-resistant group [adjusted odds ratio (AOR): 0.46; 95% CI: 0.27–0.77], the NNRTI-resistant group (AOR: 0.42; 95% CI: 0.22–0.78) and the efavirenz/nevirapine-resistant group (AOR: 0.41; 95% CI: 0.21–0.81).

Conclusions

Our study reveals a moderate prevalence of PDR in Southwest China, significantly associated with increased risk of attrition and virologic failure, particularly amongst patients with resistance to efavirenz/nevirapine. Our findings strongly advocate for routine PDR testing prior to ART initiation to guide optimal first-line treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsDrug Resistance, ViralAnti-HIV AgentsHIV-1HumansChinaFemaleMaleCohort StudiesAdultViral LoadMiddle AgedBenzoxazinesCyclopropanesAlkynesPrevalenceReverse Transcriptase Inhibitors

Substanzen

Anti-HIV AgentsBenzoxazinesCyclopropanesAlkynesefavirenzReverse Transcriptase Inhibitors

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, School of Public Health, Guangxi Medical University, Nanning 530028, China.
  • Guangxi Center for Disease Control and Prevention, Nanning 530028, China.
  • State Key Laboratory of Infectious Disease Prevention and Control (SKLID), National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innov…

ORCID-Profile: Jianjun Li, Hui Xing, Lingjie Liao, Yiming Shao

Förderung

  • National Natural Science Foundation of China
  • Guangxi Key Research and Development Program
  • Ministry of Science and Technology of China
  • Guangxi Key Laboratory of AIDS Prevention Control and Translation
  • Guangxi Bagui Honor Scholarship, Guangxi Medical and Health Key Discipline Construction Project

Zitieren

APA

Qin, L., Xie, Y., Li, J., Zhong, G., Chen, J., Zhu, Q., Liang, S., Xing, H., Liao, L., Feng, Y., Shao, Y., Ruan, Y., Lan, G., & Chen, H. (2026). Effect of pretreatment HIV drug resistance on mortality, attrition and viral suppression in patients initiating antiretroviral therapy and genetic transmission network: an observational cohort study in Southwest China. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag073

Vancouver

Qin L, Xie Y, Li J, Zhong G, Chen J, Zhu Q, et al. Effect of pretreatment HIV drug resistance on mortality, attrition and viral suppression in patients initiating antiretroviral therapy and genetic transmission network: an observational cohort study in Southwest China. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkag073

BibTeX
@article{Qin2026,
  author = {Qin, Litai and Xie, Yihong and Li, Jianjun and Zhong, Ge and Chen, Jin and Zhu, Qiuying and Liang, Shujia and Xing, Hui and Liao, Lingjie and Feng, Yi and Shao, Yiming and Ruan, Yuhua and Lan, Guanghua and Chen, Huanhuan},
  title = {Effect of pretreatment HIV drug resistance on mortality, attrition and viral suppression in patients initiating antiretroviral therapy and genetic transmission network: an observational cohort study in Southwest China},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  doi = {10.1093/jac/dkag073}
}
Kostenlos starten →